Ironwood Pharmaceuticals is trading higher, with no clear company-specific or market catalyst identified.
- Trading at $3.95, up 5.33%.
- No October 8 company announcement was identified; the investor-relations page lists September 3 as its latest release.
- Broader conditions were weak, including biotech-sector and major-index declines, so they do not explain the gain.